Arctic Bioscience — Regulatory Filings 2025

Aug 12, 2025

Arctic Bioscience launches new skin care product - Romega Skin Refine

Arctic Bioscience launches new skin care product - Romega Skin Refine

Arctic Bioscience launches Romega® Skin Refine, a dietary supplement that builds

on the company's solid experience with advanced healthcare products, based on

herring roe. Our new launch marks our entry into a large, global and growing

market segment within "Beauty and Skincare", with an estimated market size of

550-700 billion USD and growing with an estimated 7-8 % annually.

The product is already available on Romega.no, and during the third quarter of

2025 it will be launched in China, in collaboration with our partner Kotler

Marketing Group China. The product will also be launched in Sweden this autumn

and will mark the start of our subscription-based direct-to-consumer (B2C)

expansion with a rollout in several European countries through 2026.

"We have a high level of expertise and solid experience in developing new

products with herring roe oil, so this is a natural step forward for us", says

CEO Christer Valderhaug.

Romega® Skin Refine contains a unique combination of natural ingredients that

support the skin's beauty and vitality from within, with important nourishment

for the skin.

"We are well aware of the unique properties of herring roe oil. Now we have

combined this with other well-documented ingredients with benefits especially

for the skin, and I believe that Romega® Skin Refine sets a completely new

standard in natural skin care", says Steffen Eidal, Commercial Director B2C at

Arctic Bioscience.

"With over 30 years of experience in both product development and eCommerce, I

know how important it is to offer products that are well-documented. Developing

this product has taken both time and been demanding, but we know the importance

this can have. We are proud to launch a product that provides both benefit and

joy to customers, and at the same time elevates natural skin care to a whole new

level. I dare say that there is no similar dietary supplement for the skin",

concludes Eidal.

More about the product: https://romega.no/produkt/romega-skin-refine/

For more information, kindly contact:

Christer L. Valderhaug

CEO

Mobil: +47 920 84 601

E-post: christer@arctic-bioscience.com

Steffen Eidal

Commercial Director B2C

Mobil: +47 906 30 450

E-post: steffen@arctic-bioscience.com

About Arctic Bioscience

Arctic Bioscience is a biotech company developing and commercializing

pharmaceutical and nutraceutical products based on unique bioactive marine

compounds.

The company is developing HRO350 - a novel oral drug candidate. HRO350 is being

developed for treatment of patients with mild-to-moderate psoriasis. This is a

large patient group in need of new effective medicines with beneficial safety

profile.

Nutraceuticals from Arctic Bioscience are sold globally as bulk ingredients as

well as finished goods under the ROMEGA® brand.

Arctic Bioscience is led by a highly skilled team of talents with diverse and

highly relevant background.